XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share |
Earnings Per Share | Note 13 Earnings Per Share ​ The Company calculates earnings per share under the two-class method, as certain non-vested share awards contain non-forfeitable rights to dividends. As such, these awards are considered securities that participate in the earnings of the Company. Non-vested shares are discussed further in note 11. ​ The Company had 38,094,105 and 37,806,148 shares of Class A common stock outstanding as of March 31, 2025 and 2024, respectively, exclusive of issued non-vested restricted shares. Certain stock options and non-vested restricted shares are potentially dilutive securities, but are not included in the calculation of diluted earnings per share because to do so would have been anti-dilutive for the three months ended March 31, 2025 and 2024. ​ The following table illustrates the computation of basic and diluted earnings per share for the three months ended March 31, 2025 and 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended March 31,
​ | ​ | 2025 | ​ | 2024
Net income | ​ | $ | 24,231 | ​ | $ | 31,391
Less: income allocated to participating securities | ​ | ​ | (182) | ​ | ​ | (64)
Income allocated to common shareholders | ​ | $ | 24,049 | ​ | $ | 31,327
Weighted average shares outstanding for basic earnings per common share | ​ | ​ | 38,068,455 | ​ | ​ | 38,031,358
Dilutive effect of equity awards | ​ | ​ | 161,414 | ​ | ​ | 157,122
Weighted average shares outstanding for diluted earnings per common share | ​ | ​ | 38,229,869 | ​ | ​ | 38,188,480
Basic earnings per share | ​ | $ | 0.63 | ​ | $ | 0.82
Diluted earnings per share | ​ | ​ | 0.63 | ​ | ​ | 0.82
​ The Company had 560,386 and 749,123 outstanding stock options to purchase common stock at weighted average exercise prices of $32.93 and $30.94 per share at March 31, 2025 and 2024, respectively, which have time-vesting criteria, and as such, any dilution is derived only for the timeframe in which the vesting criteria had been met and where the inclusion of those stock options is dilutive. The Company had 147,955 and 148,538 unvested performance stock units issued as of March 31, 2025 and 2024, respectively, which have performance, market and/or time-vesting criteria, and as such, any dilution is derived only for the timeframe in which the vesting criteria had been met and where the inclusion of those units is dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration